use of pro-kinetics, length of hospital stay and 30-days readmission to the hospital for pain or other US-TAP-block related complications RESULTS: A total of 100 patients who underwent RARP were eligible for the analysis; 57 received the US-TAP block with 20 ml of 0.35% Ropivacaine (US-TAP-block group) and 43 did not receive US-TAP block (no-US-TAP group). All the patients received the local wound anaesthetic infiltration with 20 ml of 0.35% Ropivacaine. US-TAP block group showed a decreased mean NRS (2.7vs1.8; p[0.04) and reduced use of opioid (8 vs 2; p[0.01) in the first 24 h. Moreover, we found a shorter mean LOS (4.7 vs 4.2; p[ 0.04) with a reduced use of pro-kinetics during the hospital stay (31 vs 12; p<0.001). No US-TAP-block related complications to were reported.
INTRODUCTION AND OBJECTIVES:
In the United States, there are more than 115 deaths per day from an overdose of opioids. Previous studies from the US have reported that approximately 5% of opioid-ïve surgical patients become chronic opioid users after a single prescription postoperatively. The aim of our study was to examine the risk of chronic opioid use following radical prostatectomy (RP) in a different health care system. METHODS: We assessed filled prescriptions for opioids in 25,703 men in Prostate Cancer data Base Sweden (PCBaSe)[1] who had undergone retropubic or robot-assisted RP in 2007-2018. Opioid use was examined in three time periods: preoperative (13 months to 1 month before RP), perioperative (1 month before and 1 month after RP), and postoperative (1 to 12 months after RP). Multivariable logistic regression was used to assess the risk of transition to chronic opioid use, defined as one or more opioid prescription(s) in three consecutive months more than two months after surgery.
RESULTS: The median age at RP was 64 years and 86% of men had a Charlson comorbidity index of 0. A total of 1.9% of men had filled an opioid prescription in the preoperative period, followed by a spike in the perioperative period (59%), which sharply decreased in the second month. In the postoperative period, the percentage of men who had filled an opioid prescription was 2.3% (i.e 0.4% higher than in the preoperative period). Among chronic late users, 43% were new users. Unmarried status, low educational level, retropubic RP, high comorbidity, and more advanced risk category were predictors of transition to chronic use of opioids.
CONCLUSIONS: Slightly more than half of Swedish men received opioid prescriptions surrounding radical prostatectomy. The absolute number of patients who became chronic opioid users after surgery was low. Socioeconomic status, comorbidity, cancer characteristics, and surgical approach were all associated with risk of becoming a new chronic user after radical prostatectomy.
Source of Funding: none

PD45-03 SUPERIOR SHORT-AND LONG-TERM CONTINENCE AFTER EARLY MICTURITION ON DAY TWO AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY WITH SUPRAPUBIC TUBE PLACEMENT e A RANDOMIZED PROSPECTIVE TRIAL
Nina Harke*, Essen, Germany; Christian Wagner, Katarina Urbanova, Mustapha Addali, Jorn H. Witt, Gronau, Germany INTRODUCTION AND OBJECTIVES: In former studies, suprapubic tube placement after radical prostatectomy has been shown to be equivalent to a transurethral catheterization concerning complication rates and stricture rates with potential benefits regarding patients' comfort. This prospective randomized trial elucidates the perioperative and long-term functional outcomes depending on type and duration of catheterization after robot-assisted radical prostatectomy.
METHODS: 198 patients were randomized prospectively (May 2016-June 2017): a transurethral catheter was placed in the control group with micturition on postoperative day (POD) 5 (A), while a suprapubic tube (SPT) was used in group B and C. In B, micturition was allowed on POD 5, in C on POD 2. To investigate patient comfort, numeric rating scale for movement and rest was used and usage of pain medication. Functional outcomes were evaluated with a 12-hour Pad test, residual volume analysis on POD 5 (A, B) and POD 2 (C), usage of pads after 4 weeks and up to 12 months and IPSS.
RESULTS: After drop-out of 11 patients, no statistically significant differences could be found in patients' characteristics, perioperative or tumor-related data. Median overall bother was comparable for periods of movement (NRS for A: 2.4; B: 2.1; C: 2.2; p[0.39) and for rest (NRS for A: 1.4; B: 1.4; C: 1.2; p[0.80) with similar intake of pain medication, p[0.07. No differences could be observed in catheter related complications (p[0.86) and prolonged catheterization time occurred in six patients (A: 3; B: 1; C: 2; p[0.61). Median residual urine volume after removal of the catheter was 17 ml for A, 7 ml for B and 11 ml for C (p[0.07). A significantly better continence was observed for group C with 14 ml vs. 30 ml (A) and 24 ml (B) in the 12-hour PAD test on the day of catheter removal, p[0.007. After four weeks, 63% of the patients in C were continent (defined as use of no pad/day) compared to 33% in A and 41% in B, p[0.004. After 12 months, 76% patients were continent in A, 87% in B and 94% in C, p[0.023. CONCLUSIONS: Suprapubic tube placement instead of transurethral catheterization in robot-assisted radical prostatectomy can be performed safely without an increased risk of perioperative
